First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE

Abstract

This is the first described case of effective and durable cytoreduction after PRRT with 177Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine tumor.